ALX Oncology Holdings (ALXO) Balance Sheet: Assets & Liabilities

ALX Oncology Holdings (ALXO) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), ALX Oncology Holdings reported total assets of $59.05M and total liabilities of $33.06M. Shareholders' equity was $25.98M, down 77.1% from $113.62M a year earlier. Total debt stood at $9.75M against $44.79M in cash and short-term investments, a net cash position of $35.04M. That puts debt-to-equity at 0.38, compared with 0.09 a year earlier.

ALX Oncology Holdings Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for ALX Oncology Holdings Inc. (ALXO) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Current Assets
Cash and Cash Equivalents	16.37	17.57	22.41	48.82	363.67	434.22	9.02	8.26
Short-Term Investments	28.42	110.19	160.33	217.39	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	44.79	127.76	182.74	266.21	363.67	434.22	9.02	8.26
Accounts Receivable	0.30	0.89	1.00	0.00	0.00	0.00	0.54	0.93
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	5.94	6.60	5.92	4.76	3.35	1.77	0.26	1.01
Total Current Assets	50.73	134.35	188.66	270.97	367.02	435.99	9.81	10.21
Non-Current Assets
Property, Plant & Equipment (Net)	1.20	2.91	3.59	9.81	0.90	0.05	0.86	0.96
Long-Term Investments	3.49	3.52	35.41	16.70	0.00	0.00	0.00	0.00
Other Non-Current Assets	3.63	6.99	14.89	0.29	12.27	0.01	0.01	0.00
Total Non-Current Assets	8.32	13.42	53.89	35.52	13.16	0.06	0.87	0.96
Total Assets	59.05	147.78	242.55	306.49	380.18	436.05	10.68	11.16
Current Liabilities
Accounts Payable	4.91	4.65	9.13	8.07	5.39	0.00	3.75	0.70
Short-Term Debt	5.22	0.44	1.58	1.04	1.48	0.00	0.00	0.00
Current Portion of Long-Term Debt	5.22	0.44	-	-	-	-	-	-
Accrued Liabilities	14.42	13.42	26.87	12.84	9.90	3.68	-	-
Other Current Liabilities	14.42	2.39	11.97	2.05	1.19	2.35	1.24	1.18
Total Current Liabilities	24.55	18.50	36.00	28.33	15.30	6.20	4.98	1.87
Non-Current Liabilities
Long-Term Debt	4.53	9.47	9.64	9.39	0.00	0.00	5.42	0.00
Other Non-Current Liabilities	3.98	6.19	7.20	5.31	1.84	0.01	0.41	0.00
Total Non-Current Liabilities	8.51	15.66	16.84	14.70	1.84	0.01	5.97	0.14
Total Liabilities	33.07	34.16	52.84	43.03	17.13	6.21	10.95	2.01
Stockholders' Equity
Common Stock	0.05	0.05	0.00	0.04	0.04	0.04	0.00	0.00
Retained Earnings	-722.82	-621.12	-486.27	-325.47	-201.99	-118.52	-72.78	-53.54
Accumulated Other Comprehensive Income	0.03	0.28	0.26	-0.85	0.00	0.00	0.00	-1.02
Additional Paid-in Capital	748.72	734.41	675.68	589.74	564.99	548.33	2.14	2.78
Shares Outstanding	54.39	53.05	49.95	40.86	40.59	-	-	-
Total Stockholders' Equity	25.98	113.62	189.71	263.46	363.05	429.85	-0.28	9.16
Total Liabilities & Equity	59.05	147.78	242.55	306.49	380.18	436.05	10.68	11.16

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About ALX Oncology Holdings Balance Sheet

How much debt does ALX Oncology Holdings have?

ALX Oncology Holdings had total debt of $9.75M as of Dec 31, 2025, against $44.79M in cash and short-term investments. Its debt-to-equity ratio was 0.38. Total debt was $9.90M a year earlier.

What are ALX Oncology Holdings's total assets?

ALX Oncology Holdings reported total assets of $59.05M as of Dec 31, 2025, down 60.0% from $147.78M a year earlier. Total liabilities were $33.06M.

What is ALX Oncology Holdings's shareholders' equity?

ALX Oncology Holdings's shareholders' equity was $25.98M as of Dec 31, 2025, or about $0.48 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition